Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 24,273Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Takeda Receives EU Approval for FRUZAQLA
Takeda Receives EU Approval for FRUZAQLA

22 Jun 2024

// PRESS RELEASE

https://www.takeda.com/newsroom/newsreleases/2024/approval-from-european-commission-for-fruzaqla/

PRESS RELEASE
22 Jun 2024

https://www.onclive.com/view/trifluridine-tipiracil-plus-bevacizumab-provides-potential-first-line-alternative-to-bevacizumab-capecitabine-in-mcrc

ONCLIVE
30 Aug 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214008

FDA
13 Jun 2023

https://www.globenewswire.com/news-release/2022/10/13/2534194/35550/en/XBiotech-Announces-First-Patient-Enrolled-into-the-French-National-Cancer-Institute-INCA-Sponsored-Phase-I-II-III-Clinical-Study-for-Natrunix-Therapy-for-Colorectal-Cancer.html

GLOBENEWSWIRE
13 Oct 2022

https://www.globenewswire.com/news-release/2022/04/28/2431533/35550/en/XBiotech-Announces-French-National-Agency-ANSM-Approval-and-National-Cancer-Institute-INSA-funding-to-Support-Phase-I-II-III-Clinical-Study-for-Natrunix-in-Combination-with-Triflur.html

GLOBENEWSWIRE
28 Apr 2022

https://www.indiainfoline.com/article/news-top-story/natco-pharma-launches-tipanat-tablets-for-advanced-colorectal-gastric-cancer-treatment-in-india-121111800397_1.html

INDIAINFOLINE
23 Nov 2021